| Sep 2 |
Class I |
Fresenius Kabi USA, LLC Drug |
Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20. Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles. |
| Aug 26 |
Class I |
Fresenius Kabi USA, LLC Drug |
Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or Intravenous use, Rx only, Fresenius Kabi, Lake Zurich, IL. Unit of Use NDC Number 76045-004-01; Unit of Sale N… Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL. |
| Jul 29 |
Class II |
Fresenius Kabi USA, LLC Drug |
Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; NDC Vial: 63323-286-… Presence of Particulate Matter: Hair was found in products |
| Jul 29 |
Class II |
Fresenius Kabi USA, LLC Drug |
Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01 Presence of Particulate Matter: Hair was found in products |
| Jul 29 |
Class II |
Fresenius Kabi USA, LLC Drug |
Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL per vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-208-05; NDC Vial: 63323-208-01 Presence of Particulate Matter: Hair was found in products |
| Jul 29 |
Class II |
Fresenius Kabi USA, LLC Drug |
Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-57; NDC Vial: 63323-485-03 Presence of Particulate Matter: Hair was found in products |
| Jul 29 |
Class II |
Fresenius Kabi USA, LLC Drug |
Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07 Presence of Particulate Matter: Hair was found in product |
| Jun 17 |
Class III |
Fresenius Kabi USA, LLC Drug |
Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-696-02 (vial), NDC 63323-696-25 (carton) Failed Impurities/Degradations Specifications |
| Jun 10 |
Class II |
Fresenius Kabi USA, LLC Device |
The Large Volume Pump (LVP) of the Ivenix Infusion System (IIS). Model Number: LVP-0004. Potential for the Cassette Loading Lever to break. |
| Jun 10 |
Class I |
Fresenius Kabi USA, LLC Device |
LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005. Potential software anomaly that can cause the pump to report a false battery-health value (typically 69%) and trigger a battery-depletion alarm that will shut down the pump unless it is reconnected to AC mains power. |
| Jun 10 |
Class I |
Fresenius Kabi USA, LLC Device |
Ivenix Infusion System (IIS), Large Volume Pump, Model Number: LVP-0004 Fresenius Kabi has been made aware via customer complaints that dropping or severe jarring of the Ivenix LVP may cause damage to internal components that may not be apparent or readily visible and the devices therefore remained in service. More specifically, drops or jarring on a hard surface can cause the touchscreen input cable to loosen, resulting in unintended touchscreen behavior on the LVP, including random screen touches and/or lack of screen responsiveness to user input. Under the reported failure condition, unintended touch inputs may register at arbitrary screen locations without user interaction. These inputs occur intermittently and without a predictable pattern. |
| Apr 15 |
Class II |
Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-470-05, Unit of… Lack of Assurance of Sterility |
| Apr 15 |
Class II |
Fresenius Kabi USA, LLC Drug |
0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 63323-626-03, Un… Lack of Assurance of Sterility |
| Apr 15 |
Class II |
Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex bag, 500 mL x 20, Manufactured for: Fresenius Kabi USA, LLC ("Fresenius Kabi"), IL 60047, Unit of Use NDC: 65219-432-20… Lack of Assurance of Sterility |
| Apr 15 |
Class II |
Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 100 mL in a 100 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 600047, Unit of Use NDC: 65219-468-05, Uni… Lack of Assurance of Sterility |
| Apr 15 |
Class II |
Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL in a 500 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-472-05, Unit of… Lack of Assurance of Sterility |
| Apr 15 |
Class II |
Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freeflex bag, Rx only, BD Beckton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manuf… Lack of Assurance of Sterility |
| Apr 15 |
Class II |
Fresenius Kabi USA, LLC Drug |
5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-456-05, Unit of Sale NDC Number: 65219-456-60. Lack of Assurance of Sterility |
| Apr 15 |
Class II |
Fresenius Kabi USA, LLC Drug |
5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-458-05, Unit of Sale NDC Number: 65219-458-30. Lack of Assurance of Sterility |
| Apr 15 |
Class II |
Fresenius Kabi USA, LLC Drug |
5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-464-05, Unit of Sale NDC Number: 65219-464-50. Lack of Assurance of Sterility |